Tech Stock News
Friday, March 31, 2023
Citius Pharmaceuticals Inc (NASDAQ: CTXR) closed at $3.69 on Friday, up 2.5%. Its yearly range is $0.78 – $3.87. Inching closer to its all-time high, the biopharmaceutical company has a market capitalization of 499.90M USD. The company, which aims to create care products for cancer patients, has recently appointed Dr. […]
The stock of Citius Pharmaceuticals Inc (NASDAQ: CTXR) was maintained at $3.23.This company is pleased to usher in a leading scholar in Acute Respiratory Distress Syndrome (ARDS) to its scientific advisory board. The new official is called Dr. John Laffey, and he is expected to be of great value in helping the company […]